Orchestra BioMed Holdings, Inc. Operating Cash Flow
Orchestra BioMed Holdings, Inc. (OBIO) reported Operating Cash Flow of -$41.50 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-10
- Orchestra BioMed Holdings, Inc. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$19.33M.
- Orchestra BioMed Holdings, Inc. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$22.17M.
- Orchestra BioMed Holdings, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$2.27M.
- Orchestra BioMed Holdings, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$14.55M.
- Orchestra BioMed Holdings, Inc. net cash provided by (used in) operating activities for fiscal 2025 was -$48.96M.
- Orchestra BioMed Holdings, Inc. net cash provided by (used in) operating activities for fiscal 2024 was -$50.56M.
- Orchestra BioMed Holdings, Inc. net cash provided by (used in) operating activities for fiscal 2023 was -$46.13M.
- Orchestra BioMed Holdings, Inc. net cash provided by (used in) operating activities for fiscal 2022 was -$29.29M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 3 month as first filed | Net Cash Provided by (Used in) Operating Activities 4 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 6 month as first filed | Net Cash Provided by (Used in) Operating Activities 7 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 9 month as first filed | Net Cash Provided by (Used in) Operating Activities 12 month | Net Cash Provided by (Used in) Operating Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$19.33M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | -$41.50M 10-Q · filed 2026-08-10 | -$43.77M derived: sum of 3 quarters · filed 2026-08-10 | -$58.32M derived: sum of 4 quarters · filed 2026-08-10 | ||||||
| 2026-03-31 | -$22.17M 10-Q · filed 2026-05-12 | -$24.44M derived: sum of 2 quarters · filed 2026-05-12 | -$38.99M derived: sum of 3 quarters · filed 2026-05-12 | -$54.52M derived: sum of 4 quarters · filed 2026-08-10 | ||||||
| 2025-12-31 | -$2.27M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | -$16.82M derived: sum of 2 quarters · filed 2026-03-12 | -$32.35M derived: sum of 3 quarters · filed 2026-08-10 | -$48.96M 10-K · filed 2026-03-12 | ||||||
| 2025-09-30 | -$14.55M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | -$30.08M derived: sum of 2 quarters · filed 2026-08-10 | -$46.69M 10-Q · filed 2025-11-10 | -$60.23M derived: sum of 4 quarters · filed 2026-08-10 | ||||||
| 2025-06-30 | -$15.53M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | -$32.14M 10-Q · filed 2026-08-10 | -$45.68M derived: sum of 3 quarters · filed 2026-08-10 | -$59.38M derived: sum of 4 quarters · filed 2026-08-10 | ||||||
| 2025-03-31 | -$16.62M 10-Q · filed 2026-05-12 | -$30.15M derived: sum of 2 quarters · filed 2026-05-12 | -$43.85M derived: sum of 3 quarters · filed 2026-05-12 | -$54.06M derived: sum of 4 quarters · filed 2026-05-12 | ||||||
| 2024-12-31 | -$13.54M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | -$27.24M derived: sum of 2 quarters · filed 2026-03-12 | -$37.44M derived: sum of 3 quarters · filed 2026-03-12 | -$50.56M 10-K · filed 2026-03-12 | ||||||
| 2024-09-30 | -$13.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | -$23.91M derived: sum of 2 quarters · filed 2025-11-10 | -$37.02M 10-Q · filed 2025-11-10 | -$47.99M derived: sum of 4 quarters · filed 2025-11-10 | ||||||
| 2024-06-30 | -$10.21M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | -$23.32M 10-Q · filed 2025-08-12 | -$34.29M derived: sum of 3 quarters · filed 2025-08-12 | -$44.58M derived: sum of 4 quarters · filed 2025-08-12 | ||||||
| 2024-03-31 | -$13.11M 10-Q · filed 2025-05-12 | -$24.09M derived: sum of 2 quarters · filed 2025-05-12 | -$34.37M derived: sum of 3 quarters · filed 2025-05-12 | -$44.86M derived: sum of 4 quarters · filed 2025-05-12 | ||||||
| 2023-12-31 | -$10.97M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | -$21.26M derived: sum of 2 quarters · filed 2025-03-31 | -$31.75M derived: sum of 3 quarters · filed 2025-03-31 | -$46.13M 10-K · filed 2025-03-31 | ||||||
| 2023-09-30 | -$10.28M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$20.77M derived: sum of 2 quarters · filed 2024-11-12 | -$35.15M 10-Q · filed 2024-11-12 | -$43.90M derived: sum of 4 quarters · filed 2024-11-12 | ||||||
| 2023-06-30 | -$10.49M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | -$24.87M 10-Q · filed 2024-08-12 | -$33.62M derived: sum of 3 quarters · filed 2024-08-12 | -$40.87M derived: sum of 4 quarters · filed 2024-08-12 | ||||||
| 2023-03-31 | -$14.38M 10-Q · filed 2024-05-13 | -$23.13M derived: sum of 2 quarters · filed 2024-05-13 | -$30.38M derived: sum of 3 quarters · filed 2024-05-13 | -$38.35M derived: sum of 4 quarters · filed 2024-05-13 | ||||||
| 2022-12-31 | -$8.74M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-27 | -$16.00M derived: sum of 2 quarters · filed 2024-03-27 | -$23.96M derived: sum of 3 quarters · filed 2024-03-27 | -$29.29M 10-K · filed 2024-03-27 | -$1.58M 10-K · filed 2023-01-25 | |||||
| 2022-09-30 | -$7.26M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | -$15.22M derived: sum of 2 quarters · filed 2023-11-13 | -$20.55M 10-Q · filed 2023-11-13 | -$1.02M 10-Q · filed 2022-11-14 | -$20.57M derived: sum of 4 quarters · filed 2023-11-13 | |||||
| 2022-06-30 | -$7.96M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | -$13.29M 10-Q · filed 2023-08-10 | -$447.76K 10-Q · filed 2022-08-15 | -$13.32M derived: sum of 3 quarters · filed 2023-08-10 | -$13.45M derived: sum of 4 quarters · filed 2023-08-10 | |||||
| 2022-03-31 | -$5.32M 10-Q · filed 2023-05-12 | -$335.58K 10-Q · filed 2022-05-13 | -$5.35M derived: sum of 2 quarters · filed 2023-05-12 | -$5.48M derived: sum of 3 quarters · filed 2023-05-12 | -$5.52M derived: sum of 4 quarters · filed 2023-05-12 | |||||
| 2021-12-31 | -$28.84K derived: 10-K 12 month − 10-Q 9 month · filed 2023-01-25 | -$156.84K derived: sum of 2 quarters · filed 2023-01-25 | -$195.99K derived: sum of 3 quarters · filed 2023-01-25 | -$272.36K 10-K · filed 2023-01-25 | ||||||
| 2021-09-30 | -$128.01K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$167.15K derived: sum of 2 quarters · filed 2022-11-14 | -$243.53K 10-Q · filed 2022-11-14 | |||||||
| 2021-06-30 | -$39.14K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | -$115.52K 10-Q · filed 2022-08-15 | ||||||||
| 2021-03-31 | -$76.37K 10-Q · filed 2022-05-13 | |||||||||
| 2020-12-31 | -$258.51K 10-K/A · filed 2022-03-31 | |||||||||
| 2020-09-30 | -$247.52K 10-Q/A · filed 2022-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |